earnings
NA
NASDAQ · NAMS
NewAmsterdam Pharma Company N.V.
Healthcare · Biotechnology
$18.90
Up+$0.01 (+0.05%)
Updated Nov 8, 2026, 8:17 PM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.1B
- P/E ratio
- -19.49
- Dividend yield
- 0.00%
- 52-week range
- $18.50 – $42.21
- Volume
- 1.71M
- Avg. volume
- 1.15M
Price performance · NAMS
NAMS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
NAMS closed at $18.90 after 20 trading sessions, down 11.06% for the selected period.
- Last close
- $18.90
- Period change
- -11.06%
- Period low
- $18.89
- Period high
- $21.58
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $19.10 | $19.385 | $18.50 | $18.90 | 1.71M |
| Nov 5, 2026 | $20.77 | $20.77 | $18.86 | $18.89 | 1.56M |
| Nov 4, 2026 | $22.26 | $22.26 | $19.81 | $20.93 | 1.89M |
| Nov 3, 2026 | $19.74 | $20.46 | $19.59 | $19.90 | 2.07M |
| Nov 2, 2026 | $20.23 | $20.955 | $19.545 | $19.56 | 2.01M |
| Oct 30, 2026 | $20.60 | $20.94 | $19.78 | $20.06 | 1.14M |
| Oct 29, 2026 | $21.45 | $21.725 | $20.55 | $20.76 | 1.03M |
| Oct 28, 2026 | $20.59 | $21.115 | $20.09 | $21.07 | 1.45M |
| Oct 27, 2026 | $19.50 | $20.60 | $19.32 | $20.50 | 1.97M |
| Oct 26, 2026 | $19.68 | $19.98 | $19.265 | $19.53 | 1.56M |
| Oct 23, 2026 | $21.39 | $21.39 | $19.13 | $19.71 | 2.31M |
| Oct 22, 2026 | $21.25 | $22.251 | $21.25 | $21.58 | 1.7M |
| Oct 21, 2026 | $21.58 | $22.29 | $21.31 | $21.49 | 1.25M |
| Oct 20, 2026 | $20.57 | $21.94 | $20.36 | $21.50 | 1.08M |
| Oct 19, 2026 | $19.99 | $20.60 | $19.845 | $20.47 | 724.79K |
| Oct 16, 2026 | $20.51 | $20.665 | $19.71 | $19.83 | 1.94M |
| Oct 15, 2026 | $20.30 | $21.12 | $20.21 | $20.62 | 881.96K |
| Oct 14, 2026 | $20.08 | $20.75 | $19.58 | $20.01 | 2.19M |
| Oct 13, 2026 | $21.20 | $21.335 | $20.04 | $20.19 | 989.72K |
| Oct 12, 2026 | $21.28 | $21.97 | $21.04 | $21.25 | 812.29K |
Latest NAMS news
The latest Smart Investors Daily articles mentioning NAMS.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

